Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-10-12
1997-09-09
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514365, 514367, 514375, 548179, 548217, 548205, A61K 3142
Patent
active
056657374
ABSTRACT:
Novel compounds which are effective PDE IV inhibitors are disclosed. The compounds possess improved PDE IV inhibition as compared to theophylline or rolipram, with improved selectivity with regard to, e.g., PDE III inhibition.
REFERENCES:
patent: 3136771 (1964-06-01), Leichti et al.
patent: 3494919 (1970-02-01), Collins et al.
patent: 3541100 (1970-11-01), Ramirez
patent: 3574218 (1971-04-01), Hideg et al.
patent: 3674781 (1972-07-01), Schinzel et al.
patent: 3706834 (1972-12-01), Schellenbaum et al.
patent: 4020165 (1977-04-01), Hubbard
patent: 4025636 (1977-05-01), Dunwell et al.
patent: 4025637 (1977-05-01), Dunwell et al.
patent: 4167628 (1979-09-01), Kormawy et al.
patent: 4416892 (1983-11-01), Dawson
patent: 4652654 (1987-03-01), Verga et al.
patent: 4831152 (1989-05-01), Itoh et al.
patent: 4910211 (1990-03-01), Imamura
patent: 5190942 (1993-03-01), Poss
patent: 5206255 (1993-04-01), Ubasawa et al.
patent: 5264589 (1993-11-01), Corey
patent: 5322847 (1994-06-01), Marfat et al.
patent: 5451596 (1995-09-01), Ullrich
patent: 5496853 (1996-03-01), Shiota et al.
Isomura et al. Chem. Abstr. vol. 100 Abstract 103220 (1984).
"Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes", C. David Nicholson, R. A. John Challiss and Mohammed Shahid, 1991, Elsevier Science Publishers Ltd. (UK), TIPS 12:19-27.
"Phosphodiesterase inhibitors: new opportunities for the treatment of asthma", Theodore J. Torphy, Bradley J. Undem, Thorax 1991; 46:512-523.
"Novel phosphodiesterase inhibitors for the therapy of asthma", Theodore J. Torphy, George P. Livi and Siegfried B. Christensen, DN&P 6(4), May 1993 203-214.
"Assay of cyclic nucleotide phosphodiesterase and resolution of multiple molecular forms of the enzyme", W. Joseph Thompson, Wesley L. Terasaki, Paul M. Epstein, Samuel J. Strada, Advances in Cyclic Nucleotide Research, vol. 10, 1979, 69-92.
"Identification, characterization and functional role of phosphodiesterase isozymes in human airway smooth muscle", Theodore J. Torphy, Bradley J. Undem, Lenora B. Cieslinski, Mark A. Luttmann, Martin L. Reeves and Douglas W. P. Hay, The Journal of Pharmacology and Experimental Therapeutics, 1993, vol. 265, No. 3, 1213-1223.
"The PDE IV family of calcium-independent phosphodiesterase enzymes", John A. Lowe III and John B. Cheng, Drugs of the Future 1992, 17(9): 799-807.
Cavalla John David
Chasin Mark
Dolby Lloyd J.
Hofer Peter
Daus Donald G.
Euro-Celtique S.A.
LandOfFree
Substituted benzoxazoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted benzoxazoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benzoxazoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-70317